Skip to main content

Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030

Us Orphan Drug Rare Disease Market Offers US$ 190 Billion Opportunity Highlights Kuick Research Delhi, Oct. 31, 2025 (GLOBE NEWSWIRE) — Kuick Research announces the release of its latest study on the US Orphan Drug Market, offering investors, venture capital firms, and equity strategists a detailed and actionable perspective on one of the most resilient and rapidly expanding segments of the biopharmaceutical industry. The report, constructed from an integrated research framework, encapsulates the financial, regulatory, and scientific dynamics driving the evolution of this market. Based on an extensive review of designated orphan products, pricing benchmarks, and clinical pipelines, the study provides an exhaustive investment intelligence map for those seeking exposure to the rare disease therapeutics domain. US Orphan Designated...

Continue reading

Form 8.3 – [IDOX PLC – 30 10 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Continue reading

Fresnillo to Acquire Probe Gold for C$780 Million

Cash consideration of C$3.65 per Share represents 39% premium to Probe’s closing price The Board unanimously recommends Probe Shareholders vote in FAVOUR of the Transaction TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) — PROBE GOLD INC. (TSX: PRB) (OTCQB: PROBF) (“Probe” or the “Company”) is pleased to announce that it has entered into a definitive agreement (the “Arrangement Agreement”) pursuant to which Fresnillo plc (the “Purchaser” or “Fresnillo”) has agreed to acquire all of the issued and outstanding common shares of Probe (the “Shares”) by way of a statutory plan of arrangement under the Business Corporations Act (Ontario) (the “Transaction”). Fresnillo plc is the world’s largest primary silver producer and Mexico’s largest gold producer, listed on the London and Mexican Stock Exchanges (FRES). The company operates eight mines...

Continue reading

Elis announces the acquisition of Larosé in Germany

Elis announces the acquisition of Larosé in Germany Saint-Cloud, October 31, 2025 – Elis, the global leader in circular services at work, today announces the acquisition of 100% of Larosé GmbH and Mitteldeutsche Wäscherei GmbH (“Larosé”). Larosé serves the eastern part of Germany through its two laundries located in Schönebeck and Berlin. The company caters mainly to healthcare clients and offers a wide range of rental and laundry services in flat linen, workwear, and resident linen. Larosé employs around 145 people. This acquisition strengthens the Elis network in Germany, particularly in Berlin, where the Group previously did not operate a laundry. The company generated approximately 13 million euros in revenue in 2024 and will be consolidated in the financial statements from November 1, 2025. About Elis As the leader in circular services,...

Continue reading

NorthStrive® Companies Inc. Advises on the Successful Closing of the Acquisition of Indarg Engineering, Inc., a California-Based Precision CNC Manufacturer

NEWPORT BEACH, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — NorthStrive Companies Inc. (“NorthStrive”), is pleased to announce that it served as advisor and transaction leader for the acquisition by PMGC Holdings Inc. (“PMGC”), a diversified public holding company executing a targeted U.S. manufacturing roll-up strategy. The acquisition involves all of the operating assets of Indarg Engineering, Inc. (“Indarg”), a precision CNC machining business founded in 1985 and based in Hawthorne, California. Indarg brings nearly four decades of experience delivering high-tolerance components, rapid prototyping and quality-certified production across aerospace, defense, and industrial sectors. The Hawthorne facility will be rebranded under the AGA Precision Systems LLC (“AGA”) alongside AGA’s existing Santa Ana headquarters. Transaction Highlights:Acquirer:...

Continue reading

Millicom (Tigo) acquires Telefónica Ecuador for USD 380 Million, strengthening its South American footprint

Millicom (Tigo) acquires Telefónica Ecuador for USD 380 Million, strengthening its South American footprint Luxembourg, October 30, 2025 – Millicom International Cellular S.A. (“Millicom”) today announced the successful completion of its USD 380 million acquisition of Telefónica’s telecommunications operations in Ecuador. This transaction represents another major step in Millicom’s strategy to deepen its presence in South America, following the company’s recent acquisition of Telefónica Uruguay. With this addition, Millicom expands its footprint into a new, high-potential market—Ecuador, a dollarized economy characterized by stability, solid macroeconomic fundamentals, and a strong demand for advanced digital services. Marcelo Benitez, CEO of Millicom, commented: “This acquisition underscores our long-term confidence in Latin America and...

Continue reading

FAIRCHILD COMPLETES A NEVADA TRINITY WITH THE ACQUISITION OF ADVANCED STAGE CARLIN QUEEN PROJECT

Fairchild Completes a Nevada Trinity with Acquisition of Advanced Stage Carlin Queen ProjectFigure 1 – Carlin Queen ProjectVANCOUVER, B.C., Oct. 30, 2025 (GLOBE NEWSWIRE) — via IBN – Fairchild Gold Corp. (“Fairchild” or the “Company”) (TSXV: FAIR, Frankfurt: Y4Y, OTCID: FCHDF), is pleased to announce that it has entered into a Binding Purchase Agreement (“BPA”) dated October 30th , 2025, with a private arm’s length party, to acquire a 100% interest in the drill-ready Carlin Queen gold and silver property strategically located along the Midas- and Carlin Gold Mines Trends in Nevada. The property comprises 73 unpatented lode mining claims totaling 1,508 acres. Carlin Queen Project: Drill-Ready, Multiple Target Gold-Silver Property Carlin Queen is an advanced stage gold-silver exploration project situated at the intersection...

Continue reading

Palomar Holdings, Inc. Announces Agreement to Acquire The Gray Casualty & Surety Company

Builds Scale in the Attractive Surety Market LA JOLLA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ: PLMR) (“Palomar”, the “Company”) today announced that it has entered into a definitive agreement to acquire The Gray Casualty & Surety Company (“Gray Surety”) from Bernhard Capital Partners (“BCP”) and The Gray Insurance Company for total consideration of $300 million in cash subject to customary closing adjustments. The transaction has been approved by both Gray Surety and Palomar’s boards of directors and is expected to close during the first half of 2026, subject to regulatory approvals and other customary closing conditions. Gray Surety is a Treasury-listed surety carrier specializing in contract bonds for midsized and emerging contractors across the United States. Led by an experienced, entrepreneurial...

Continue reading

Kuick Research Report Maps Next Wave Of M&A Opportunities In Global Cancer Antibodies Drug Conjugates Market

Global Cancer Antibody Drug Conjugates Market Opportunity USD 70 Billion Opportunty By 2031 Delhi, Oct. 30, 2025 (GLOBE NEWSWIRE) — Kuick Research has unveiled its latest comprehensive report on the Global Cancer Antibody Drug Conjugate (ADC) Market, a 1300 page study that serves as a strategic guide for investors, venture capital firms, and equity analysts exploring mergers and acquisitions in the biopharmaceutical sector. With oncology innovation accelerating globally, this report offers a data-driven foundation for identifying high-value opportunities in one of the most rapidly expanding segments of cancer therapeutics. Antibody Drug Conjugates combine the precision of targeted antibodies with the potency of cytotoxic drugs, creating a powerful and selective approach to cancer treatment. The report maps more than 800 ADC candidates...

Continue reading

Fengate acquires 16 medical outpatient facilities in the United States

MIAMI, Oct. 30, 2025 (GLOBE NEWSWIRE) — Fengate Asset Management (Fengate) is pleased to announce the expansion of its healthcare infrastructure portfolio with the acquisition 16 medical outpatient facilities in the United States. The acquisition brings the firm’s healthcare infrastructure portfolio to more than 80 facilities, totaling over $1 billion in assets. The facilities provide high-acuity healthcare services including ambulatory surgery, radiology, oncology, and orthopedics to communities across 10 states. “This acquisition builds on our firm’s strategy of developing or acquiring specialized and essential healthcare infrastructure assets anchored by high-quality health systems or private operators,” said Mac Bell, Managing Director, Head of Social and Transportation at Fengate. Fengate acquired the facilities alongside...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.